Physician profile
Mark T Mueller
NPI 1063464923
$5,465.08
in general payments reported to CMS, 2019-2025
38 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $876 · 2020: $390 · 2021: $1,116 · 2022: $1,602 · 2023: $1,131 · 2024: $134 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,481.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $908.92 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $735.78 | 2021-2023 | |
| Lilly USA, LLC | $552.26 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals Lp | $451.61 | 2019-2023 | Farxiga, Breztri, Fasenra |
| Pfizer INC. | $383.52 | 2019-2023 | |
| Amgen INC. | $235.95 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $172.75 | 2019-2023 | Steglatro, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.82 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $162.99 | 2019-2022 | |
| Exact Sciences Corporation | $153.38 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $148.59 | 2022 | |
| Glaxosmithkline, LLC. | $122.34 | 2019-2025 | Bexsero, Menveo, Pediarix |
| Biohaven Pharmaceuticals, INC. | $120.33 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $106.48 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.45 | 2019-2023 | Xifaxan |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.